IL-17C在肾脏缺血再灌注损伤中具有致病作用
该研究探讨IL-17C在急性肾损伤中的作用。患者和小鼠急性肾损伤肾活检中IL-17C显著升高,缺氧可上调肾小管上皮细胞IL-17C。小鼠缺血再灌注损伤中,中和IL-17C抗体或敲除IL-17RE可减轻肾小管损伤、氧化应激和炎症,并降低TH17活化、IL-17A及下游TNF-α、IL-1β。
要点
- 急性肾损伤患者和小鼠肾活检中IL-17C显著升高
- 中和IL-17C或敲除IL-17RE可减轻小鼠肾缺血再灌注损伤
- 抑制IL-17C/IL-17RE可能成为急性肾损伤治疗新策略
核心结论
- IL-17C可能参与急性肾损伤的炎症反应。
- 抑制IL-17C或阻断IL-17RE可能是治疗急性肾损伤的新策略。
研究设计与样本
- 研究检测了急性肾损伤患者和小鼠肾活检中IL-17C表达。
- 在小鼠肾缺血再灌注损伤模型中,使用IL-17C中和抗体或IL-17RE敲除。
- 体外实验在肾小管细胞中采用缺氧暴露及siRNA敲低IL-17C或沉默IL-17RE。
主要发现
- 急性肾损伤患者和小鼠肾活检中IL-17C显著升高。
- 缺氧诱导肾小管上皮细胞IL-17C上调。
- 中和IL-17C或敲除IL-17RE减轻肾小管损伤、肾脏氧化应激和炎症。
- IL-17C中和与IL-17RE敲除均减弱小鼠肾脏TH17活化和IL-17A表达。
- IL-17C抗体预处理和IL-17RE敲除小鼠中TNF-α和IL-1β降低。
临床怎么用
- 关注IL-17C/IL-17RE通路作为急性肾损伤炎症干预的潜在靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cytokines are necessary to trigger the inflammatory response in kidney ischemia/reperfusion injury. Interleukin-17C (IL-17C), a unique member of the IL-17 family, is a cytokine produced by epithelial cells implicated in host defense and autoimmune diseases. However, little is known about the role of IL-17C in acute kidney injury. We investigated this and found that IL-17C was significantly increased in kidney biopsies of patients and mice with acute kidney injury. Exposure to hypoxia induced upregulation of IL-17C in kidney tubular epithelial cells. To further investigate the role of IL-17C, kidney ischemia/reperfusion injury was induced in mice. Inhibition of IL-17C action with a neutralizing antibody or IL-17 receptor E (IL-17RE) knockout attenuated tubular injury, kidney oxidative stress, and kidney inflammation. Mechanistically, both IL-17C neutralization and IL-17RE knockout attenuated TH17 activation and IL-17A expression in kidneys of mice with acute kidney injury. TNF-α and IL-1β, downstream cytokines of IL-17C, were also reduced in IL-17C antibody pretreated and IL-17RE knockout mice. Additionally, IL-17C knockdown with siRNA decreased hypoxia-induced inflammation in kidney tubular cells and silencing IL-17RE abrogated the effects of IL-17C in kidney tubular cells. Thus, IL-17C may participate in the inflammatory response of acute kidney injury and inhibition of IL-17C or blockade of IL-17 RE may be a novel therapeutic strategy for the treatment of acute kidney injury.
引用
- Wang F, Yin J, Lin Y, et al. IL-17C has a pathogenic role in kidney ischemia/reperfusion injury. Kidney Int. 2020. PMID: 32331702. doi:10.1016/j.kint.2020.01.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。